SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-263824
Filing Date
2019-10-07
Accepted
2019-10-07 17:08:06
Documents
12
Period of Report
2019-10-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d818165d8k.htm   iXBRL 8-K 23585
  Complete submission text file 0001193125-19-263824.txt   149592

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA jazz-20191003.xsd EX-101.SCH 3076
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE jazz-20191003_lab.xml EX-101.LAB 18840
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jazz-20191003_pre.xml EX-101.PRE 11843
14 EXTRACTED XBRL INSTANCE DOCUMENT d818165d8k_htm.xml XML 3535
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 191141385
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences